Biotec - I'm a Buyer of This.

i see a lot more positive catl is for biote than we have seen last year. The ond one is just pipe line of drug approvals that should accelerate. There's forty eight different drugs that are waiting there in the pipe line. Theyre clinical trials that weren't able to be conducted, their inspections that had to be unwhole because of covet. But as we recover from this post covert world, i think some of that activity resumes. And by the way, j p morgan, a health er confedences next week. I think that could be a good catalist for to start looking on a byotecx stocks here.